GLSI

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Greenwich Lifesciences Inc

NASDAQ | GLSI

8.35

USD

$0.00

(

0.00%

)

At Close (As of Nov 26, 2025)

$115.69M

Market Cap

-

P/E Ratio

-1.46

EPS

$15.47

52 Week High

$7.78

52 Week Low

HEALTHCARE

Sector

GLSI Chart

Recent Chart
Price Action

GLSI Technicals

Tags:

GLSI Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$3.6K
Total Revenue $0
Cost Of Revenue $3.6K
Costof Goods And Services Sold $3.6K
Operating Income -$16M
Selling General And Administrative $3.1M
Research And Development $13M
Operating Expenses $16M
Investment Income Net -
Net Interest Income $223K
Interest Income $223K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.6K
Income Before Tax -$16M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$16M
Comprehensive Income Net Of Tax -
Ebit -$16M
Ebitda -$16M
Net Income -$16M

Revenue & Profitability

Earnings Performance

GLSI Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $4.1M
Total Current Assets $4.1M
Cash And Cash Equivalents At Carrying Value $4.1M
Cash And Short Term Investments $4.1M
Inventory -
Current Net Receivables -
Total Non Current Assets $1.8K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $1.8K
Intangible Assets Excluding Goodwill $1.8K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets -
Other Non Current Assets -
Total Liabilities $1.6M
Total Current Liabilities $1.6M
Current Accounts Payable $1.2M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $382K
Other Non Current Liabilities -
Total Shareholder Equity $2.5M
Treasury Stock -
Retained Earnings -$66M
Common Stock $13K
Common Stock Shares Outstanding $13M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$7.3M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $3.6K
Capital Expenditures $3
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $4.4M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$16M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$3.6K
Total Revenue $0
Cost Of Revenue $3.6K
Costof Goods And Services Sold $3.6K
Operating Income -$16M
Selling General And Administrative $3.1M
Research And Development $13M
Operating Expenses $16M
Investment Income Net -
Net Interest Income $223K
Interest Income $223K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.6K
Income Before Tax -$16M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$16M
Comprehensive Income Net Of Tax -
Ebit -$16M
Ebitda -$16M
Net Income -$16M

GLSI News

GLSI Profile

Greenwich Lifesciences Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company headquartered in Stafford, Texas, dedicated to pioneering immunotherapies aimed at treating cancer, with a particular emphasis on HER2/neu-expressing tumors such as breast cancer. The company's lead candidate, GP2, is designed to enhance the immune system's ability to target and eliminate cancer cells, addressing critical unmet needs within the oncology landscape. As Greenwich LifeSciences advances its promising pipeline of therapies, it is strategically positioned to make significant contributions to cancer care and improve patient outcomes in a rapidly evolving therapeutic environment.

LPTX
+368.57%
$2.05
NVDA
+1.37%
$180.26
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+117.39%
$1.06
INHD
-16.32%
$0.22
ZYXI
+115.62%
$1.59
VINE
+10.76%
$0.39
AMZE
+10.76%
$0.39
ONDS
-2.36%
$8.24
AMBR
+56.32%
$2.47
BITF
+11.91%
$3.10
PLUG
+1.53%
$1.98
NIO
-0.72%
$5.46
IPG
-1.95%
$24.57
ASST
+1.80%
$1.13
CLSK
+13.79%
$13.45
AXDX
-61.36%
$0.03
AAL
+3.49%
$13.93
TSLA
+1.71%
$426.58
CIFR
+9.30%
$19.15
SOFI
+0.56%
$28.49
INTC
+2.73%
$36.81
BMNR
+9.78%
$31.74
GPUS
+15.78%
$0.33
GOOGL
-1.07%
$319.95
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-34.15%
$0.12
MARA
-0.53%
$11.11
WULF
+6.45%
$14.84
HOOD
+10.92%
$128.20
RUBI
-8.19%
$0.21
KVUE
+1.11%
$17.22
F
+0.15%
$13.19
AMD
+3.93%
$214.24
SNDK
-2.47%
$215.04
SOND
-23.45%
$0.12
WBD
+4.00%
$23.88
DNN
+3.64%
$2.56
RMBL
+60.50%
$3.21
TLRY
+4.76%
$1.03
BTBT
+2.65%
$2.32
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
AMZN
-0.22%
$229.16
ADD
-25.47%
$0.05
GRAB
+1.52%
$5.32
BMNU
+18.42%
$7.52
RIG
+6.17%
$4.30
RIVN
+3.98%
$16.18
PW
+18.87%
$0.99
SRM
+53.27%
$10.30
PLTR
+1.35%
$165.77
PFE
-0.03%
$25.71
AAPL
+0.20%
$277.55
HBAN
+0.55%
$16.27
IVP
-20.80%
$0.13
BBD
+3.95%
$3.68
AGNC
+1.53%
$10.56
CETY
-11.20%
$2.06
BTG
+3.23%
$4.47
BAC
+0.97%
$52.99
KALA
+42.62%
$0.91
CCL
-1.12%
$25.43
BULL
+6.43%
$9.26
SNAP
-0.39%
$7.61
GOOG
-1.03%
$320.28
TWOH
0.00%
$0.00
ACHR
+1.49%
$7.49
RGTI
-1.95%
$25.57
CRWV
+4.20%
$74.29
AVGO
+3.25%
$397.57
WLGS
-5.57%
$0.04
VALE
+2.62%
$12.51
ABEV
0.00%
$2.51
NFLX
+1.66%
$106.14
MTSR
-0.35%
$70.50
PLTD
-1.37%
$7.16
T
-0.15%
$25.82
AEHL
+8.43%
$3.47
IREN
+2.06%
$48.45
ORCL
+4.02%
$204.96
UPWK
-0.55%
$19.58
NTNX
-17.74%
$48.34
MSFT
+1.78%
$485.50
ITUB
+3.23%
$7.66
DVLT
-3.61%
$2.13
PCG
+1.78%
$16.01
NOK
+0.33%
$6.08
DEFT
+20.86%
$1.39
CMG
+1.88%
$34.03
AFMD
-34.94%
$0.18
KOS
-1.83%
$1.07
HBI
-0.45%
$6.59
CAN
+0.75%
$0.92
HPQ
-1.39%
$23.98
BURU
+7.72%
$0.22
PLTZ
-2.62%
$7.43
APLD
+5.05%
$24.94
LPTX
+368.57%
$2.05
NVDA
+1.37%
$180.26
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+117.39%
$1.06
INHD
-16.32%
$0.22
ZYXI
+115.62%
$1.59
VINE
+10.76%
$0.39
AMZE
+10.76%
$0.39
ONDS
-2.36%
$8.24
AMBR
+56.32%
$2.47
BITF
+11.91%
$3.10
PLUG
+1.53%
$1.98
NIO
-0.72%
$5.46
IPG
-1.95%
$24.57
ASST
+1.80%
$1.13
CLSK
+13.79%
$13.45
AXDX
-61.36%
$0.03
AAL
+3.49%
$13.93
TSLA
+1.71%
$426.58
CIFR
+9.30%
$19.15
SOFI
+0.56%
$28.49
INTC
+2.73%
$36.81
BMNR
+9.78%
$31.74
GPUS
+15.78%
$0.33
GOOGL
-1.07%
$319.95
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-34.15%
$0.12
MARA
-0.53%
$11.11
WULF
+6.45%
$14.84
HOOD
+10.92%
$128.20
RUBI
-8.19%
$0.21
KVUE
+1.11%
$17.22
F
+0.15%
$13.19
AMD
+3.93%
$214.24
SNDK
-2.47%
$215.04
SOND
-23.45%
$0.12
WBD
+4.00%
$23.88
DNN
+3.64%
$2.56
RMBL
+60.50%
$3.21
TLRY
+4.76%
$1.03
BTBT
+2.65%
$2.32
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
AMZN
-0.22%
$229.16
ADD
-25.47%
$0.05
GRAB
+1.52%
$5.32
BMNU
+18.42%
$7.52
RIG
+6.17%
$4.30
RIVN
+3.98%
$16.18
PW
+18.87%
$0.99
SRM
+53.27%
$10.30
PLTR
+1.35%
$165.77
PFE
-0.03%
$25.71
AAPL
+0.20%
$277.55
HBAN
+0.55%
$16.27
IVP
-20.80%
$0.13
BBD
+3.95%
$3.68
AGNC
+1.53%
$10.56
CETY
-11.20%
$2.06
BTG
+3.23%
$4.47
BAC
+0.97%
$52.99
KALA
+42.62%
$0.91
CCL
-1.12%
$25.43
BULL
+6.43%
$9.26
SNAP
-0.39%
$7.61
GOOG
-1.03%
$320.28
TWOH
0.00%
$0.00
ACHR
+1.49%
$7.49
RGTI
-1.95%
$25.57
CRWV
+4.20%
$74.29
AVGO
+3.25%
$397.57
WLGS
-5.57%
$0.04
VALE
+2.62%
$12.51
ABEV
0.00%
$2.51
NFLX
+1.66%
$106.14
MTSR
-0.35%
$70.50
PLTD
-1.37%
$7.16
T
-0.15%
$25.82
AEHL
+8.43%
$3.47
IREN
+2.06%
$48.45
ORCL
+4.02%
$204.96
UPWK
-0.55%
$19.58
NTNX
-17.74%
$48.34
MSFT
+1.78%
$485.50
ITUB
+3.23%
$7.66
DVLT
-3.61%
$2.13
PCG
+1.78%
$16.01
NOK
+0.33%
$6.08
DEFT
+20.86%
$1.39
CMG
+1.88%
$34.03
AFMD
-34.94%
$0.18
KOS
-1.83%
$1.07
HBI
-0.45%
$6.59
CAN
+0.75%
$0.92
HPQ
-1.39%
$23.98
BURU
+7.72%
$0.22
PLTZ
-2.62%
$7.43
APLD
+5.05%
$24.94
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.